X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (132994) 132994
Newsletter (7666) 7666
Newspaper Article (4383) 4383
Patent (774) 774
Book Chapter (768) 768
Magazine Article (464) 464
Dissertation (403) 403
Book / eBook (109) 109
Conference Proceeding (77) 77
Publication (62) 62
Reference (43) 43
Trade Publication Article (40) 40
Web Resource (34) 34
Transcript (26) 26
Paper (7) 7
Streaming Video (7) 7
Book Review (6) 6
Government Document (6) 6
Journal / eJournal (3) 3
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (54198) 54198
humans (51487) 51487
male (43832) 43832
fatty acids (36662) 36662
female (30498) 30498
fatty liver (25191) 25191
liver (25155) 25155
rats (23265) 23265
metabolism (20249) 20249
liver - metabolism (19319) 19319
mice (17987) 17987
obesity (17194) 17194
lipids (16846) 16846
biochemistry & molecular biology (16733) 16733
research (16006) 16006
adult (15036) 15036
diet (14963) 14963
middle aged (14441) 14441
insulin resistance (13626) 13626
physiological aspects (12948) 12948
nutrition & dietetics (12113) 12113
insulin-resistance (11775) 11775
liver diseases (11449) 11449
endocrinology & metabolism (11025) 11025
lipid metabolism (10940) 10940
gastroenterology & hepatology (10731) 10731
analysis (10517) 10517
inflammation (10357) 10357
fatty acids - metabolism (10303) 10303
risk factors (9955) 9955
proteins (9649) 9649
cholesterol (9591) 9591
gene expression (9561) 9561
glucose (9488) 9488
oxidative stress (9265) 9265
diabetes (9194) 9194
insulin (9071) 9071
metabolic syndrome (8940) 8940
rodents (8393) 8393
liver - pathology (8107) 8107
liver - drug effects (7873) 7873
non-alcoholic fatty liver disease (7826) 7826
expression (7786) 7786
fatty liver-disease (7546) 7546
health aspects (7478) 7478
aged (7429) 7429
cell biology (7303) 7303
steatosis (7108) 7108
physiology (7080) 7080
fatty-acids (7019) 7019
enzymes (6988) 6988
triglycerides (6932) 6932
disease (6879) 6879
nutrition (6514) 6514
medical research (6372) 6372
mice, inbred c57bl (6261) 6261
pharmacology & pharmacy (6178) 6178
fibrosis (6001) 6001
fatty liver - pathology (5902) 5902
research article (5893) 5893
medicine (5867) 5867
gene-expression (5608) 5608
hepatic steatosis (5595) 5595
multidisciplinary sciences (5571) 5571
life sciences (5512) 5512
body weight (5363) 5363
medicine, experimental (5308) 5308
nonalcoholic steatohepatitis (5231) 5231
adipose-tissue (5193) 5193
food science & technology (5149) 5149
fatty liver - metabolism (4980) 4980
triglycerides - blood (4933) 4933
type 2 diabetes (4860) 4860
metabolites (4859) 4859
dietary supplements (4813) 4813
fatty acids, nonesterified - blood (4787) 4787
steatohepatitis (4761) 4761
studies (4726) 4726
liver - enzymology (4719) 4719
unsaturated fatty acids (4696) 4696
disease models, animal (4652) 4652
rats, wistar (4627) 4627
prevalence (4619) 4619
medicine, research & experimental (4548) 4548
oxidation (4528) 4528
care and treatment (4527) 4527
body mass index (4464) 4464
triglycerides - metabolism (4433) 4433
oxidation-reduction (4414) 4414
pregnancy (4392) 4392
rats, sprague-dawley (4378) 4378
apoptosis (4369) 4369
cancer (4357) 4357
homeostasis (4357) 4357
diabetes mellitus (4301) 4301
risk (4181) 4181
nonalcoholic fatty liver disease (4178) 4178
time factors (4178) 4178
fatty liver - etiology (4159) 4159
blood glucose - metabolism (4027) 4027
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Online Resources - Online (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Chemistry (A D Allen) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Theses (1) 1
Scarborough Hospital - Online (1) 1
University Archives - Archives (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (140503) 140503
German (1913) 1913
Japanese (1897) 1897
French (1100) 1100
Chinese (1039) 1039
Russian (1024) 1024
Spanish (655) 655
Portuguese (545) 545
Korean (524) 524
Italian (517) 517
Danish (323) 323
Polish (220) 220
Hungarian (105) 105
Czech (99) 99
Swedish (97) 97
Dutch (67) 67
Persian (67) 67
Ukrainian (64) 64
Turkish (58) 58
Romanian (52) 52
Norwegian (50) 50
Slovak (44) 44
Bulgarian (34) 34
Serbian (14) 14
Croatian (12) 12
Icelandic (10) 10
Finnish (9) 9
Bosnian (4) 4
Hebrew (4) 4
Indonesian (4) 4
Arabic (3) 3
Lithuanian (3) 3
Slovenian (3) 3
Catalan (2) 2
Estonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


World journal of gastroenterology : WJG, ISSN 1007-9327, 11/2013, Volume 19, Issue 41, pp. 6969 - 6978
...), a protein is expressed in the liver and is involved in lipid metabolism, has recently been identified as a major determinant of liver fat content... 
Liver disease | Patatin-like phospholipase domain-containing 3 | Chronic hepatitis C virus hepatitis | Genetics | Hepatocellular carcinoma | Nonalcoholic fatty liver disease | Single nucleotide polymorphism | Fibrogenesis | Alcoholic liver disease | Steatosis | CHRONIC HEPATITIS-C | NONALCOHOLIC STEATOHEPATITIS | GREATER-THAN-G | B-VIRUS INFECTION | HEPATOCELLULAR-CARCINOMA | INSULIN-RESISTANCE | FATTY LIVER | DOMAIN-CONTAINING 3 | GENETIC VARIANT | GASTROENTEROLOGY & HEPATOLOGY | GENOME-WIDE ASSOCIATION | Cholangitis, Sclerosing - enzymology | Hepatitis C, Chronic - pathology | Fatty Liver - pathology | Humans | Cholangitis, Sclerosing - genetics | Fatty Liver - complications | Hepatitis B, Chronic - enzymology | Hepatitis C, Chronic - complications | Liver Cirrhosis - enzymology | Hemochromatosis - pathology | Fatty Liver, Alcoholic - genetics | Hepatitis B, Chronic - genetics | Liver Cirrhosis, Alcoholic - enzymology | Hepatitis C, Chronic - enzymology | Fatty Liver - enzymology | Non-alcoholic Fatty Liver Disease | Liver Neoplasms - pathology | Fatty Liver, Alcoholic - pathology | Liver Neoplasms - enzymology | Fatty Liver, Alcoholic - enzymology | Hepatitis B, Chronic - pathology | Liver Cirrhosis - genetics | Hemochromatosis - genetics | Fatty Liver - genetics | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Liver Cirrhosis, Alcoholic - pathology | Membrane Proteins - genetics | Risk Factors | Hemochromatosis - enzymology | Disease Progression | Polymorphism, Genetic | Cholangitis, Sclerosing - pathology | Fatty Liver, Alcoholic - complications | Liver Cirrhosis, Alcoholic - genetics | Phenotype | Liver Cirrhosis - pathology | Carcinoma, Hepatocellular | Hepatitis C, Chronic - genetics | Lipase - genetics | Review | Gastroenterologi | Hepatocellular | Gastroenterology and Hepatology
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2018, Volume 155, Issue 2, pp. 443 - 457.e17
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 10, p. e0186715
Journal Article
Journal of molecular medicine (Berlin, Germany), ISSN 1432-1440, 2016, Volume 94, Issue 6, pp. 613 - 627
Liver disease is a growing global health problem, as deaths from end-stage liver cirrhosis and cancer are rising across the world... 
Human Genetics | Viral hepatitis | Biomedicine | Fatty liver | Internal Medicine | Hepatocellular carcinoma | Molecular Medicine | HIF2α | HIF1α | Ischemia-reperfusion liver injury | Alcoholic liver disease | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATED PROTEIN-KINASE | ADENOSINE A(2A) RECEPTOR | NONALCOHOLIC STEATOHEPATITIS | ISCHEMIA-REPERFUSION INJURY | HIF2 alpha | HEPATOCELLULAR-CARCINOMA | LIPID-ACCUMULATION | HEPATITIS-C VIRUS | X PROTEIN | GENETICS & HEREDITY | HIF1 alpha | UP-REGULATION | Bevacizumab - therapeutic use | Oligonucleotides - therapeutic use | Fatty Liver - pathology | Humans | Fatty Liver - therapy | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Hepatitis, Viral, Human - genetics | Liver Neoplasms - therapy | Molecular Targeted Therapy | Liver Diseases, Alcoholic - genetics | Liver Diseases, Alcoholic - therapy | Basic Helix-Loop-Helix Transcription Factors - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Carcinoma, Hepatocellular - genetics | Liver Cirrhosis - metabolism | Liver Neoplasms - pathology | Liver Cirrhosis - genetics | Fatty Liver - genetics | Liver Diseases, Alcoholic - pathology | Basic Helix-Loop-Helix Transcription Factors - genetics | Fatty Liver - metabolism | Liver Neoplasms - genetics | Signal Transduction | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Hepatitis, Viral, Human - therapy | Gene Expression Regulation | Basic Helix-Loop-Helix Transcription Factors - antagonists & inhibitors | Clinical Trials as Topic | Liver Cirrhosis - therapy | Liver Diseases, Alcoholic - metabolism | Hepatitis, Viral, Human - pathology | Animals | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Hepatitis, Viral, Human - metabolism | Liver Cirrhosis - pathology | Carcinoma, Hepatocellular - therapy | Carcinoma, Hepatocellular - metabolism | Liver diseases | Physiological aspects | Development and progression | Genetic aspects | DNA binding proteins | Research | Diagnosis | Review
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2017, Volume 65, Issue 4, pp. 1165 - 1180
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2012, Volume 143, Issue 2, pp. 307 - 320
.... JNK isozymes regulate cell death and survival, differentiation, proliferation, ROS accumulation, metabolism, insulin signaling, and carcinogenesis in the liver... 
Gastroenterology and Hepatology | c-Jun | MAPK | Acetaminophen | TNF | Insulin Resistance | Hepatocellular Carcinoma | N-TERMINAL KINASE | JUN NH2-TERMINAL KINASE | ENDOPLASMIC-RETICULUM STRESS | TNF-INDUCED APOPTOSIS | KAPPA-B | MITOCHONDRIAL PERMEABILITY TRANSITION | HEPATOCYTE SURVIVAL | INSULIN-RESISTANCE | COMPENSATORY PROLIFERATION | GASTROENTEROLOGY & HEPATOLOGY | Acetaminophen - adverse effects | Liver Transplantation | Humans | JNK Mitogen-Activated Protein Kinases - metabolism | Metabolic Syndrome - metabolism | Liver - physiopathology | Metabolic Syndrome - drug therapy | MAP Kinase Signaling System | Carcinoma, Hepatocellular - drug therapy | Analgesics, Non-Narcotic - adverse effects | Cell Death | Biomarkers - metabolism | Liver Regeneration | Fatty Liver - metabolism | JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors | Liver - metabolism | Liver Neoplasms - drug therapy | Fatty Liver - drug therapy | Animals | Chemical and Drug Induced Liver Injury - metabolism | Protein Kinase Inhibitors - therapeutic use | Chemical and Drug Induced Liver Injury - drug therapy | JNK Mitogen-Activated Protein Kinases - physiology | Liver Neoplasms - metabolism | Liver - physiology | Liver Diseases - drug therapy | Mice | Primary Graft Dysfunction - metabolism | Liver Diseases - physiopathology | Liver Diseases - metabolism | Carcinoma, Hepatocellular - metabolism | Enzymes | Medical colleges | Platelet-derived growth factor | Liver diseases | Isoenzymes | Genes | Liver | Development and progression | Transforming growth factors | Fatty acids | Liver cancer | Epidermal growth factor | Interleukins | DNA | Genetically modified organisms | Physiological aspects | Insulin resistance | Tumor proteins | Mitogens | Protein kinases | Tumors | Index Medicus | Abridged Index Medicus | acetaminophen | insulin resistance | hepatocellular carcinoma
Journal Article